Join
Live feed
·
INSIDERFilingvia Quantisnow
Takeda Pharmaceutical Company Limited logo

Director Kimura Koichiro was granted 1,800 units of Ordinary Shares (SEC Form 4) (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
TAK· Takeda Pharmaceutical Company Limited
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TAK (Takeda Pharmaceutical Company Limited) and more on Quantisnow.